Logo image of SLP

SIMULATIONS PLUS INC (SLP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SLP - US8292141053 - Common Stock

17.13 USD
-0.05 (-0.29%)
Last: 11/25/2025, 8:12:58 PM
17.13 USD
0 (0%)
After Hours: 11/25/2025, 8:12:58 PM
Fundamental Rating

6

SLP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. SLP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SLP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SLP was profitable.
SLP had a positive operating cash flow in the past year.
In the past 5 years SLP has always been profitable.
In the past 5 years SLP always reported a positive cash flow from operatings.
SLP Yearly Net Income VS EBIT VS OCF VS FCFSLP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

SLP has a Return On Assets of -47.03%. This is in the lower half of the industry: SLP underperforms 74.29% of its industry peers.
Looking at the Return On Equity, with a value of -51.05%, SLP is in line with its industry, outperforming 45.71% of the companies in the same industry.
With a decent Return On Invested Capital value of 3.12%, SLP is doing good in the industry, outperforming 74.29% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 6.67%.
Industry RankSector Rank
ROA -47.03%
ROE -51.05%
ROIC 3.12%
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
SLP Yearly ROA, ROE, ROICSLP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

SLP's Profit Margin has declined in the last couple of years.
SLP has a Operating Margin of 5.82%. This is in the better half of the industry: SLP outperforms 68.57% of its industry peers.
In the last couple of years the Operating Margin of SLP has declined.
SLP has a Gross Margin (53.75%) which is in line with its industry peers.
SLP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.82%
PM (TTM) N/A
GM 53.75%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
SLP Yearly Profit, Operating, Gross MarginsSLP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

SLP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SLP has more shares outstanding
Compared to 5 years ago, SLP has more shares outstanding
There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SLP Yearly Shares OutstandingSLP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SLP Yearly Total Debt VS Total AssetsSLP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

SLP has an Altman-Z score of 20.29. This indicates that SLP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 20.29, SLP belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.29
ROIC/WACC0.31
WACC10.16%
SLP Yearly LT Debt VS Equity VS FCFSLP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

A Current Ratio of 5.11 indicates that SLP has no problem at all paying its short term obligations.
SLP's Current ratio of 5.11 is amongst the best of the industry. SLP outperforms 88.57% of its industry peers.
SLP has a Quick Ratio of 5.11. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
SLP has a better Quick ratio (5.11) than 88.57% of its industry peers.
Industry RankSector Rank
Current Ratio 5.11
Quick Ratio 5.11
SLP Yearly Current Assets VS Current LiabilitesSLP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

7

3. Growth

3.1 Past

SLP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.30%, which is quite impressive.
SLP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.41% yearly.
SLP shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.01%.
The Revenue has been growing by 15.56% on average over the past years. This is quite good.
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%

3.2 Future

Based on estimates for the next years, SLP will show a very strong growth in Earnings Per Share. The EPS will grow by 21.41% on average per year.
SLP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.40% yearly.
EPS Next Y-764.23%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
EPS Next 5Y21.41%
Revenue Next Year10.93%
Revenue Next 2Y6.11%
Revenue Next 3Y6.38%
Revenue Next 5Y9.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SLP Yearly Revenue VS EstimatesSLP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
SLP Yearly EPS VS EstimatesSLP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.35 indicates a quite expensive valuation of SLP.
SLP's Price/Earnings ratio is rather cheap when compared to the industry. SLP is cheaper than 82.86% of the companies in the same industry.
When comparing the Price/Earnings ratio of SLP to the average of the S&P500 Index (25.98), we can say SLP is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 42.14, the valuation of SLP can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SLP is on the same level as its industry peers.
SLP's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.79.
Industry RankSector Rank
PE 26.35
Fwd PE 42.14
SLP Price Earnings VS Forward Price EarningsSLP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SLP indicates a somewhat cheap valuation: SLP is cheaper than 68.57% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SLP is valued a bit cheaper than the industry average as 62.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 32.69
EV/EBITDA 22.91
SLP Per share dataSLP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)63.77
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
SLP's Dividend Yield is rather good when compared to the industry average which is at 4.65. SLP pays more dividend than 94.29% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SLP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

The dividend of SLP has a limited annual growth rate of 0.01%.
SLP has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.01%
Div Incr Years0
Div Non Decr Years0
SLP Yearly Dividends per shareSLP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

SLP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
SLP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-1.9%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
SLP Yearly Income VS Free CF VS DividendSLP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

SIMULATIONS PLUS INC

NASDAQ:SLP (11/25/2025, 8:12:58 PM)

After market: 17.13 0 (0%)

17.13

-0.05 (-0.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)07-14 2025-07-14/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners86.07%
Inst Owner Change-5.99%
Ins Owners17.37%
Ins Owner Change-1.17%
Market Cap344.83M
Revenue(TTM)80.38M
Net Income(TTM)-63.19M
Analysts80
Price Target23.46 (36.95%)
Short Float %7.07%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0.24
Dividend Growth(5Y)0.01%
DP-1.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.9%
Min EPS beat(2)0.69%
Max EPS beat(2)321.12%
EPS beat(4)2
Avg EPS beat(4)55.29%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)3
Avg EPS beat(8)16.77%
EPS beat(12)4
Avg EPS beat(12)5.67%
EPS beat(16)7
Avg EPS beat(16)7.48%
Revenue beat(2)2
Avg Revenue beat(2)0.96%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.3%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)1.3%
Revenue beat(8)5
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)1.72%
PT rev (1m)-9.21%
PT rev (3m)-9.21%
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)9.09%
EPS NY rev (1m)-30.57%
EPS NY rev (3m)-41.96%
Revenue NQ rev (1m)4.26%
Revenue NQ rev (3m)3.8%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)0.82%
Valuation
Industry RankSector Rank
PE 26.35
Fwd PE 42.14
P/S 4.29
P/FCF 32.69
P/OCF 24.28
P/B 2.79
P/tB 6.87
EV/EBITDA 22.91
EPS(TTM)0.65
EY3.79%
EPS(NY)0.41
Fwd EY2.37%
FCF(TTM)0.52
FCFY3.06%
OCF(TTM)0.71
OCFY4.12%
SpS3.99
BVpS6.15
TBVpS2.49
PEG (NY)N/A
PEG (5Y)63.77
Graham Number9.48
Profitability
Industry RankSector Rank
ROA -47.03%
ROE -51.05%
ROCE 3.77%
ROIC 3.12%
ROICexc 4.04%
ROICexgc 17.48%
OM 5.82%
PM (TTM) N/A
GM 53.75%
FCFM 13.12%
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
ROICexc(3y)12.97%
ROICexc(5y)16.03%
ROICexgc(3y)84.29%
ROICexgc(5y)97.41%
ROCE(3y)5.53%
ROCE(5y)6.08%
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-20.15%
ROICexc growth 3Y-47.05%
ROICexc growth 5Y-36.7%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 40.33%
Cap/Sales 4.55%
Interest Coverage 250
Cash Conversion 103.33%
Profit Quality N/A
Current Ratio 5.11
Quick Ratio 5.11
Altman-Z 20.29
F-Score4
WACC10.16%
ROIC/WACC0.31
Cap/Depr(3y)99.44%
Cap/Depr(5y)102.61%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.35%
Profit Quality(3y)126.28%
Profit Quality(5y)123.52%
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
EPS Next Y-764.23%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
EPS Next 5Y21.41%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
Revenue Next Year10.93%
Revenue Next 2Y6.11%
Revenue Next 3Y6.38%
Revenue Next 5Y9.4%
EBIT growth 1Y-33.13%
EBIT growth 3Y-18.34%
EBIT growth 5Y-10.46%
EBIT Next Year145.07%
EBIT Next 3Y49.49%
EBIT Next 5Y49.82%
FCF growth 1Y-52.99%
FCF growth 3Y-14.87%
FCF growth 5Y-1.4%
OCF growth 1Y-46.86%
OCF growth 3Y-11.47%
OCF growth 5Y2.73%

SIMULATIONS PLUS INC / SLP FAQ

What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SLP.


What is the valuation status for SLP stock?

ChartMill assigns a valuation rating of 3 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Overvalued.


How profitable is SIMULATIONS PLUS INC (SLP) stock?

SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.


What are the PE and PB ratios of SIMULATIONS PLUS INC (SLP) stock?

The Price/Earnings (PE) ratio for SIMULATIONS PLUS INC (SLP) is 26.35 and the Price/Book (PB) ratio is 2.79.


Can you provide the dividend sustainability for SLP stock?

The dividend rating of SIMULATIONS PLUS INC (SLP) is 4 / 10 and the dividend payout ratio is -1.9%.